BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11967038)

  • 1. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
    N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
    Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure.
    Schroth M; Plank C; Rauh M; Dörr HG; Rascher W; Dötsch J
    Eur J Endocrinol; 2006 Apr; 154(4):555-61. PubMed ID: 16556718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ; Andrews RC; Andrew R; Walker BR
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
    Główka FK; Kosicka K; Karaźniewicz-Łada M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN; Buter H; Navis GJ; Dullaart RP
    Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
    Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
    Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity.
    Inada M; Iwasaki K; Imai C; Hashimoto S
    Intern Med; 2008; 47(24):2157-64. PubMed ID: 19075542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.
    Campino C; Carvajal CA; Cornejo J; San Martín B; Olivieri O; Guidi G; Faccini G; Pasini F; Sateler J; Baudrand R; Mosso L; Owen GI; Kalergis AM; Padilla O; Fardella CE
    Endocrine; 2010 Feb; 37(1):106-14. PubMed ID: 19882252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cortisol to cortisone metabolites in hypertensive obese children.
    Csábi GY; Juricskay S; Molnár D
    J Endocrinol Invest; 2000; 23(7):435-9. PubMed ID: 11005267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.